Browsing Tag
Biotech Funding
4 posts
Can Allurion Technologies reset investor confidence with FDA momentum and a debt-free strategy?
Allurion Technologies aims to bounce back with FDA milestones, a debt-free strategy, and new capital. Will this turnaround move the stock in 2025?
Angle plc collapses after shock pivot: Executive chairman appointed as it rebrands to CelLBxHealth
Angle plc’s shares plunge 36 percent after rebranding as CelLBxHealth and appointing Jan Groen as executive chairman. Discover how this reset affects funding and investor outlook.
Ostia Sciences Inc. closes $1.46m seed financing to accelerate microbiome therapeutics platform development
Ostia Sciences Inc. secures $1.46M seed funding to advance SALI-10 microbiome therapeutics for oral health. Analysts expect strong growth in a $3B market.
Moleculin Biotech (NASDAQ: MBRX) launches stock offering to support pivotal cancer drug trial and IND filings
Moleculin Biotech to raise $5.9M to fund its Phase 3 trial for Annamycin and expand oncology pipeline. Explore what this means for AML treatment and investors.